Tower Research Capital LLC (TRC) - MERRIMACK PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$14,352
-89.0%
1,164
-89.0%
0.00%
-100.0%
Q2 2023$129,974
+866393.3%
10,567
+755.6%
0.00%
Q1 2023$15
-59.5%
1,235
-61.9%
0.00%
-100.0%
Q4 2022$37
-96.3%
3,242
+1652.4%
0.00%
Q3 2022$1,000185
+208.3%
0.00%
Q2 2022$0
-100.0%
60
-68.9%
0.00%
Q1 2022$1,000
-50.0%
193
-69.3%
0.00%
Q4 2021$2,000628
+837.3%
0.00%
Q3 2021$0
-100.0%
67
-97.4%
0.00%
Q1 2021$16,000
+23.1%
2,579
+32.4%
0.00%
Q4 2020$13,000
+550.0%
1,948
+290.4%
0.00%
Q3 2020$2,0000.0%499
-35.4%
0.00%
Q1 2020$2,000
-75.0%
773
-69.5%
0.00%
-100.0%
Q4 2019$8,000
-38.5%
2,533
-10.9%
0.00%0.0%
Q3 2019$13,000
-35.0%
2,842
-13.8%
0.00%0.0%
Q2 2019$20,000
+233.3%
3,297
+291.1%
0.00%
Q1 2019$6,000
-91.8%
843
-95.6%
0.00%
-100.0%
Q4 2018$73,000
-15.1%
19,063
+18.9%
0.01%
-16.7%
Q3 2018$86,000
+138.9%
16,028
+122.1%
0.01%
+200.0%
Q2 2018$36,000
+157.1%
7,215
+306.9%
0.00%
+100.0%
Q1 2018$14,000
-72.0%
1,773
-48.7%
0.00%
-75.0%
Q3 2017$50,0003,4530.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q4 2023
NameSharesValueWeighting ↓
Newtyn Management, LLC 633,297$3,109,0000.58%
BVF INC/IL 1,110,588$5,453,0000.53%
WITTENBERG INVESTMENT MANAGEMENT, INC. 253,752$1,246,0000.53%
Rubric Capital Management LP 476,164$2,338,0000.23%
Clearline Capital LP 59,331$291,0000.19%
Yakira Capital Management, Inc. 66,934$329,0000.08%
KEMPNER CAPITAL MANAGEMENT INC. 14,898$73,0000.05%
STONEBRIDGE CAPITAL MANAGEMENT INC 20,725$106,0000.04%
J. Goldman & Co LP 100,000$491,0000.02%
Dynamic Technology Lab Private Ltd 22,731$112,0000.02%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders